These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 635445
21. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. Schattenmann G, Ebert R, Siewert R, Creutzfeldt W. Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074 [Abstract] [Full Text] [Related]
22. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia. Ebert R, Creutzfeldt W. Acta Diabetol Lat; 1989 Mar; 26(1):1-15. PubMed ID: 2665406 [Abstract] [Full Text] [Related]
23. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus. Krarup T, Madsbad S, Moody AJ. J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559 [Abstract] [Full Text] [Related]
24. The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man. Jorde R, Burhol PG, Schulz TB, Waldum HL, Lygren I, Jenssen T, Myhre ES. Scand J Gastroenterol; 1981 Jan; 16(1):109-12. PubMed ID: 7015476 [Abstract] [Full Text] [Related]
25. Influence of caloric intake on gastric inhibitory polypeptide, VIP and gastrin release in man. Beck B, Villaume C, Chayvialle JA, Gariot P, Ulmer M, Desalme A, Debry G. Peptides; 1984 Jan; 5(2):403-6. PubMed ID: 6473163 [Abstract] [Full Text] [Related]
26. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus. Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, Andres R. Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904 [Abstract] [Full Text] [Related]
27. Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide (GIP) and vasoactive intestinal polypeptide (VIP). Villar HV, Fender HR, Rayford PL, Bloom SR, Ramus NI, Thompson JC. Ann Surg; 1976 Jul; 184(1):97-102. PubMed ID: 938120 [Abstract] [Full Text] [Related]
28. Increased plasma response of gastric inhibitory polypeptide to oral glucose and a liquid meal after prolonged starvation in healthy man. Oektedalen O, Opstad PK, Jorde R. Digestion; 1983 Jul; 26(3):114-23. PubMed ID: 6343163 [Abstract] [Full Text] [Related]
30. Effect of exogenous insulin on fasting serum levels of gastric inhibitory polypeptide (GIP) in juvenile diabetes. Talaulicar M, Ebert R, Willms B, Creutzfeldt W. Clin Endocrinol (Oxf); 1981 Feb; 14(2):175-80. PubMed ID: 7021006 [Abstract] [Full Text] [Related]
31. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Ebert R, Creutzfeldt W. Diabetologia; 1980 Sep; 19(3):198-204. PubMed ID: 6997121 [Abstract] [Full Text] [Related]
32. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Ebert R, Illmer K, Creutzfeldt W. Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554 [Abstract] [Full Text] [Related]
33. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes. Meier JJ, Gallwitz B, Askenas M, Vollmer K, Deacon CF, Holst JJ, Schmidt WE, Nauck MA. Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522 [Abstract] [Full Text] [Related]
34. Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man. Salera M, Pironi L, Giacomoni P, Venturi S, Capelli M, Miglioli M, Barbara L. Digestion; 1982 Sep; 24(2):126-32. PubMed ID: 6127273 [Abstract] [Full Text] [Related]
35. Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus. Krarup T, Madsbad S, Regeur L, Faber OK, Tronier B. Acta Endocrinol (Copenh); 1984 Feb; 105(2):221-5. PubMed ID: 6364671 [Abstract] [Full Text] [Related]
36. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes. Creutzfeldt W, Talaulicar M, Ebert R, Willms B. Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299 [Abstract] [Full Text] [Related]
37. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus. Mazzaferri EL, Starich GH, Lardinois CK, Bowen GD. J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608 [Abstract] [Full Text] [Related]
38. Gastric and extragastric gastrin release in normal subjects in duodenal ulcer patients, and in patients with partial gastrectomy (Billroth I). Fritsch WP, Hausamen TU, Rick W. Gastroenterology; 1976 Oct; 71(4):552-7. PubMed ID: 8356 [Abstract] [Full Text] [Related]
39. Inhibition of gastric secretion by fat and hypertonic glucose in the dog: role of gastric inhibitory peptide. Creutzfeldt W, Ebert R, Finke U, Konturek SJ, Kwiecień N, Radecki T. J Physiol; 1983 Jan; 334():91-101. PubMed ID: 6864570 [Abstract] [Full Text] [Related]
40. Glucose tolerance and insulin secretion in patients with chronic duodenal ulcer. Humphrey CS, Dykes JR, Johnston D. Br Med J; 1972 Nov 18; 4(5837):393-6. PubMed ID: 4637151 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]